116 related articles for article (PubMed ID: 3266192)
21. Genetic control of immunity to Heligmosomoides polygyrus: fixed H-2 E positive but not H-2 negative cells can present antigen to a parasite-specific T cell hybridoma.
Robinson M; Gustad TR; Garner SD; David CS
Parasite Immunol; 1995 May; 17(5):237-43. PubMed ID: 7675510
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production.
Knott CL; Reed JC; Bodrug S; Saedi MS; Kumar A; Kuus-Reichel K
Hybridoma; 1996 Oct; 15(5):365-71. PubMed ID: 8913786
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific B cells efficiently present low doses of antigen for induction of T cell proliferation.
Malynn BA; Romeo DT; Wortis HH
J Immunol; 1985 Aug; 135(2):980-8. PubMed ID: 2409164
[TBL] [Abstract][Full Text] [Related]
25. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
[TBL] [Abstract][Full Text] [Related]
26. Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.
Ruberti G; Sellins KS; Hill CM; Germain RN; Fathman CG; Livingstone A
J Exp Med; 1992 Jan; 175(1):157-62. PubMed ID: 1730914
[TBL] [Abstract][Full Text] [Related]
27. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.
Ronchese F; Hausmann B
J Exp Med; 1993 Mar; 177(3):679-90. PubMed ID: 8436906
[TBL] [Abstract][Full Text] [Related]
28. Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes.
Tony HP; Parker DC
J Exp Med; 1985 Jan; 161(1):223-41. PubMed ID: 3155791
[TBL] [Abstract][Full Text] [Related]
29. Immunogenic capacity of macrophage hybridomas.
Tzehoval E; Dagan S; Eisenbach L; Atsmon J; Feldman M
Eur J Immunol; 1989 Jan; 19(1):89-96. PubMed ID: 2465907
[TBL] [Abstract][Full Text] [Related]
30. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
[TBL] [Abstract][Full Text] [Related]
31. T-cell recognition and antigen presentation of myoglobin. Protein recognition by site-specific T-cell clones is influenced by amino acid substitutions outside the site.
Yoshioka M; Atassi MZ
Biochem J; 1989 Mar; 258(3):645-51. PubMed ID: 2786412
[TBL] [Abstract][Full Text] [Related]
32. B cell activation potential of insulin-reactive T cells in H-2b mice.
Huber BT; Hochman PS
Eur J Immunol; 1984 Dec; 14(12):1106-10. PubMed ID: 6083870
[TBL] [Abstract][Full Text] [Related]
33. Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis.
Brennan FR; Negroiu G; Buzás EI; Fülöp C; Holló K; Mikecz K; Glant TT
Clin Exp Immunol; 1995 Apr; 100(1):104-10. PubMed ID: 7697908
[TBL] [Abstract][Full Text] [Related]
34. Efficient isolation of mutant antigen presenting cell lines by functional selection using T cell clones.
Koarada S; Kubota E; Tokushima M; Naitoh K; Miyake K; Kimoto M
J Immunol Methods; 1995 Jun; 182(2):209-18. PubMed ID: 7790727
[TBL] [Abstract][Full Text] [Related]
35. Correlation of presentation of insulin with surface I-Ad and A alpha and A beta mRNA expression by cloned B lymphoma hybridoma variants.
Bernard NF; Reid PC; Phillips ML; Delovitch TL
Immunol Lett; 1988 Oct; 19(2):143-51. PubMed ID: 3148547
[TBL] [Abstract][Full Text] [Related]
36. Activation requirements of cloned inducer T cells. II. The failure of some clones to respond to antigen presented by activated B cells.
Dekruyff RH; Cantor H; Dorf ME
J Immunol; 1986 Jan; 136(2):446-51. PubMed ID: 3484492
[TBL] [Abstract][Full Text] [Related]
37. IA mutant functional antigen-presenting cell lines.
Glimcher LH; Hamano T; Asofsky R; Sachs DH; Pierres M; Samelson LE; Sharrow SO; Paul WE
J Immunol; 1983 May; 130(5):2287-94. PubMed ID: 6300242
[TBL] [Abstract][Full Text] [Related]
38. Conformation-dependent recognition of a protein by T-lymphocytes: apomyoglobin-specific T-cell clone recognizes conformational changes between apomyoglobin and myoglobin.
Cohly HH; Morrison DR; Atassi MZ
Immunol Invest; 1988 Jun; 17(4):337-42. PubMed ID: 3263321
[TBL] [Abstract][Full Text] [Related]
39. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity in the response of T cells to antigens presented by B lymphoma cells.
Ratcliffe MJ; Julius MH; Kim KJ
Cell Immunol; 1984 Oct; 88(1):49-60. PubMed ID: 6332682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
